Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


3 Arthritis Res Ther
1 J Bone Joint Surg Am
2 PLoS One
1 Z Rheumatol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arthritis Res Ther

  1. ISSA SF, Duer A, Ostergaard M, Horslev-Petersen K, et al
    Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets.
    Arthritis Res Ther. 2017;19:80.
    PubMed     Text format     Abstract available

  2. KUIJPER TM, Folmer R, Stolk EA, Hazes JMW, et al
    Doctors' preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment.
    Arthritis Res Ther. 2017;19:78.
    PubMed     Text format     Abstract available

  3. ANDRES CEREZO L, Sumova B, Prajzlerova K, Veigl D, et al
    Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:79.
    PubMed     Text format     Abstract available

    J Bone Joint Surg Am

  4. DEKKER TJ, Hamid KS, Easley ME, DeOrio JK, et al
    Ratio of Range of Motion of the Ankle and Surrounding Joints After Total Ankle Replacement: A Radiographic Cohort Study.
    J Bone Joint Surg Am. 2017;99:576-582.
    PubMed     Text format     Abstract available

    PLoS One

  5. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    PLoS One. 2017;12:e0175207.
    PubMed     Text format     Abstract available

  6. BOO S, Oh H, Froelicher ES, Suh CH, et al
    Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0176291.
    PubMed     Text format     Abstract available

    Z Rheumatol

    [Success for a new generation of disease-modifying antirheumatic drugs : The Janus kinase inhibitor baricitinib in rheumatoid arthritis].
    Z Rheumatol. 2017 Apr 26. doi: 10.1007/s00393-017-0307.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.